Latest Articles

This article will provide an introduction to the Immune Cell Atlas, highlight some of the research contributing to the project and explore the wider implications of the work.

In this article, Dr. Kenneth Oh discusses how a comprehensive qPCR–western blot–multiplex assay workflow can revolutionize drug discovery approaches.

Technology Networks had the pleasure of talking to Dr. Matthew Weiss to learn more about patient-derived organoids and how these disease models could be used to develop personalized treatment strategies for pancreatic cancer.

Researchers have identified a modifier gene called lymphotoxin beta receptor (LTBR) – which is not normally expressed in T cells – and combined it with CARs to create T cells that were better equipped at killing tumor cells.

This article will outline four main aspects of QC in cell culture and describe what they are and why we should carry them out.

This article explores the concept of cancer patient digital twins and how they could be used to treat cancer patients in the future.

CAR T-cell therapy is largely used to treat cancers, but here we explore how Dr. Leonardo Ferreira and his team are using CAR T-cell therapy to treat Type 1 diabetes.

Our Teach Me in 10 episodes are either technology, product or service focused. We invite you to explore the further reading and resources provided in the video description if you want to learn more about the content shared in the video – it's as easy as that.

From a cell signaling perspective, phenotypic plasticity is important because it allows cells to take on a form that aids their invasive and metastatic abilities. In this article, we explore the topic in more detail.

Researchers from NYU Grossman School of Medicine have discovered that skin cancer cells rely on amyloid beta (Aβ) to survive and thrive once they have metastasized to the brain.